BioNTech SE's stock surged 5.31% during Tuesday's intraday trading session following a company announcement regarding its upcoming financial report.
The biotech firm revealed it will report its first-quarter 2026 financial results on May 5, 2026, and will host a conference call and webcast for investors on the same day. This news appears to have generated positive market sentiment and anticipation among traders ahead of the earnings release.